Menu

勃林格殷格翰的能倍乐怎么样?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that causes shortness of breath and coughing. Helps open the airways, making it easier for air to move in and out of the lungs. Normal use of Respimat can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life. How about learning more about Boehringer Ingelheim’s Respimat?

The approval of Respimat was based on data from two pivotal Phase III trials (TONADO-1, -2). The study involved more than 5,000 COPD patients. Data showed that compared with placebo, tiotropium bromide, and olodaterol monotherapy, Respimat produced a statistically significant improvement in patients' lung function (FEV1) and had a similar safety profile to tiotropium bromide or olodaterol.

The use of Respimat helps open the airways, allowing air to move in and out of the lungs more easily. Normal use of Respimat can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life.

Boehringer Ingelheim is a pharmaceutical company dedicated to human biopharmaceutical chemistry and animal health products. It is also the world's largest privately held pharmaceutical company. Boehringer Ingelheim's main research areas include: immune and respiratory diseases, cardiovascular and metabolic diseases, central nervous system diseases, and tumors. Boehringer Ingelheim has a complete biopharmaceutical industry chain, from genetic engineering of cells to manufacturing, and commercial production of off-the-shelf medicines for external industrial customers.

The effect of Respimat lasts 24 hours, which means it only needs to be used once a day, preferably at the same time every day. Spray twice with each use. It should be noted that patients should not overdose to avoid harm to the body.

It is a long-acting anticholinergic drug with similar affinity for five choline receptors (M1-M5). It dilates bronchial smooth muscle by binding to M3 receptors on smooth muscle.

Recommended related hot articles: /newsDetail/90468.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。